Lantheus Holdings (LNTH) Return on Capital Employed (2015 - 2026)
Lantheus Holdings (LNTH) reported Return on Capital Employed of 14.85% for Q1 2026, up 999.0% year-over-year from 1.35% in Q1 2025, and down 8.36% quarter-over-quarter from 16.2% in Q4 2025.
Lantheus Holdings (LNTH) Return on Capital Employed (2015 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 12 years of Return on Capital Employed data on file, last reported at 14.85% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 14.85%, up 999.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 14.85% (up 999.0% YoY), and the FY2025 annual result was 17.56%, up 1181.0% from the prior year.
- Return on Capital Employed retreated to 14.85% in Q1 2026 per LNTH's latest filing, from 16.2% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 21.07% in Q3 2022 and troughed at 3.03% in Q1 2023.
- A 5-year average of 7.48% and a median of 5.1% in 2024 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2022 and 2025: Return on Capital Employed jumped 2442 bps in 2022, then sank 1773 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 3.77% in 2022, then soared by 64 bps to 6.17% in 2023, then declined by 17 bps to 5.1% in 2024, then surged by 218 bps to 16.2% in 2025, then declined by 8 bps to 14.85% in 2026.
- Business Quant data shows LNTH's Return on Capital Employed at 14.85% in Q1 2026, 16.2% in Q4 2025, and 1.02% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 6.92% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 14.85% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -1.92% |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 21.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.85% |
| Dec 31, 2025 | 16.20% |
| Sep 30, 2025 | -1.02% |
| Jun 30, 2025 | 3.94% |
| Mar 31, 2025 | 4.86% |
| Dec 31, 2024 | 5.10% |
| Sep 30, 2024 | 16.71% |
| Jun 30, 2024 | 11.15% |
| Mar 31, 2024 | 13.45% |
| Dec 31, 2023 | 6.17% |
| Sep 30, 2023 | 4.43% |
| Jun 30, 2023 | 2.43% |
| Mar 31, 2023 | -3.03% |
| Dec 31, 2022 | 3.77% |
| Sep 30, 2022 | 21.07% |
| Jun 30, 2022 | 9.60% |
| Mar 31, 2022 | -2.43% |
| Dec 31, 2021 | -7.95% |
| Sep 30, 2021 | -3.35% |
| Jun 30, 2021 | -2.18% |